133 related articles for article (PubMed ID: 27657735)
1. Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis.
Cai F; Xiao X; Niu X; Shi H; Zhong Y
PLoS One; 2016; 11(9):e0163534. PubMed ID: 27657735
[TBL] [Abstract][Full Text] [Related]
2. Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis.
Cai F; Xiao X; Niu X; Zhong Y
PLoS One; 2017; 12(3):e0173194. PubMed ID: 28249042
[TBL] [Abstract][Full Text] [Related]
3. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
Zuo C; Ai L; Ratliff P; Suen JY; Hanna E; Brent TP; Fan CY
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):967-75. PubMed ID: 15184253
[TBL] [Abstract][Full Text] [Related]
4. Association between P16INK4a promoter methylation and HNSCC: a meta-analysis of 21 published studies.
Shi H; Chen X; Lu C; Gu C; Jiang H; Meng R; Niu X; Huang Y; Lu M
PLoS One; 2015; 10(4):e0122302. PubMed ID: 25835498
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis.
Meng RW; Li YC; Chen X; Huang YX; Shi H; Du DD; Niu X; Lu C; Lu MX
Sci Rep; 2016 Feb; 6():20756. PubMed ID: 26857374
[TBL] [Abstract][Full Text] [Related]
6. Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis.
Gu C; Lu J; Cui T; Lu C; Shi H; Xu W; Yuan X; Yang X; Huang Y; Lu M
PLoS One; 2013; 8(9):e72633. PubMed ID: 24086261
[TBL] [Abstract][Full Text] [Related]
7. Relationships between
Yu D; Cao T; Han YD; Huang FS
Onco Targets Ther; 2016; 9():6049-6057. PubMed ID: 27785051
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
Zhang YJ; Chen Y; Ahsan H; Lunn RM; Lee PH; Chen CJ; Santella RM
Int J Cancer; 2003 Feb; 103(4):440-4. PubMed ID: 12478658
[TBL] [Abstract][Full Text] [Related]
9. The association, clinicopathological significance, and diagnostic value of
Shen Z; Zhou C; Li J; Deng H; Li Q; Wang J
Onco Targets Ther; 2016; 9():6763-6773. PubMed ID: 27826202
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.
Esteller M; Hamilton SR; Burger PC; Baylin SB; Herman JG
Cancer Res; 1999 Feb; 59(4):793-7. PubMed ID: 10029064
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
Esteller M; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Watkins DN; Issa JP; Sidransky D; Baylin SB; Herman JG
Cancer Res; 2000 May; 60(9):2368-71. PubMed ID: 10811111
[TBL] [Abstract][Full Text] [Related]
12. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
Abdel-Fattah R; Glick A; Rehman I; Maiberger P; Hennings H
Int J Cancer; 2006 Feb; 118(3):527-31. PubMed ID: 16094607
[TBL] [Abstract][Full Text] [Related]
13. [Promoter hypermethylation of DNA repair gene O6-methylguanine DNA methyltransferase in laryngeal squamous cell carcinoma].
Zhang S; Kong WJ; Liu Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):152-6. PubMed ID: 15283294
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma.
Li Q; Hong J; Shen Z; Deng H; Shen Y; Wu Z; Zhou C
Medicine (Baltimore); 2019 Oct; 98(43):e17651. PubMed ID: 31651887
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
[TBL] [Abstract][Full Text] [Related]
17. Loss expression of O6-methylguanine DNA methyltransferase by promoter hypermethylation and its relationship to betel quid chewing in oral squamous cell carcinoma.
Huang SH; Lee HS; Mar K; Ji DD; Huang MS; Hsia KT
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):883-9. PubMed ID: 20451846
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
Gilliland FD; Harms HJ; Crowell RE; Li YF; Willink R; Belinsky SA
Cancer Res; 2002 Apr; 62(8):2248-52. PubMed ID: 11956078
[TBL] [Abstract][Full Text] [Related]
19. Alterations in S-adenosylhomocysteine metabolism decrease O6-methylguanine DNA methyltransferase gene expression without affecting promoter methylation.
Hermes M; Geisler H; Osswald H; Riehle R; Kloor D
Biochem Pharmacol; 2008 Jun; 75(11):2100-11. PubMed ID: 18395186
[TBL] [Abstract][Full Text] [Related]
20. Prognosis value of MGMT promoter methylation for patients with lung cancer: a meta-analysis.
Chen C; Hua H; Han C; Cheng Y; Cheng Y; Wang Z; Bao J
Int J Clin Exp Pathol; 2015; 8(9):11560-4. PubMed ID: 26617891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
